Related references
Note: Only part of the references are listed.A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Jiangling Peng et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2022)
Effects of Combining Alcohol and Cannabis on Driving, Breath Alcohol Level, Blood THC, Cognition, and Subjective Effects: A Narrative Review
Andrew Fares et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2022)
The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis
Tao Xue et al.
SLEEP MEDICINE REVIEWS (2022)
Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial
Danielle McCartney et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2022)
Posttraumatic stress disorder, sleep and medical cannabis treatment: A daily diary study
Sharon R. Sznitman et al.
JOURNAL OF ANXIETY DISORDERS (2022)
Cannabidiol in the context of substance use disorder treatment: A systematic review
Victoria Paulus et al.
ADDICTIVE BEHAVIORS (2022)
Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges
Ryan Green et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review
Premalatha Balachandran et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2021)
Circadian rhythms and substance use disorders: A bidirectional relationship
Eduardo K. Tamura et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2021)
Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder
Carlos M. O. de Almeida et al.
MOVEMENT DISORDERS (2021)
Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation
Rosa Maria Vitale et al.
BIOMOLECULES (2021)
THC and CBD Effects on Alcohol Use Among Alcohol and Cannabis Co-Users
H. C. Karoly et al.
PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2021)
Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems
Julie Moltke et al.
JOURNAL OF CANNABIS RESEARCH (2021)
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell et al.
BRAIN RESEARCH (2020)
Interactions Between Alcohol and the Endocannabinoid System
George Kunos
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)
Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder
Yves Dauvilliers et al.
ANNALS OF NEUROLOGY (2020)
A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects
Julie Crockett et al.
EPILEPSIA (2020)
Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies
Anastasia S. Suraev et al.
SLEEP MEDICINE REVIEWS (2020)
Melatonin for Treatment-Seeking Alcohol Use Disorder patients with sleeping problems: A randomized clinical pilot trial
Marie N. S. Gendy et al.
SCIENTIFIC REPORTS (2020)
Cannabinoids, Endocannabinoids and Sleep
Andrew J. Kesner et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance A Randomized Clinical Trial
Thomas R. Arkell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cannabidiol does not display drug abuse potential in mice behavior
Adrian Viudez-Martinez et al.
ACTA PHARMACOLOGICA SINICA (2019)
Unique treatment potential of cannabidiol for the prevention of relapse to drug use
Friedbert Weiss et al.
NEUROPSYCHOPHARMACOLOGY (2019)
The Use of Cannabinoids for Sleep: A Critical Review on Clinical Trials
Nirushi Kuhathasan et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2019)
Effects of Cannabidiol on Alcohol-Related Outcomes: A Review of Preclinical and Human Research
Christina N. Nona et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2019)
Cannabidiol Adverse Effects and Toxicity
Marilyn A. Huestis et al.
CURRENT NEUROPHARMACOLOGY (2019)
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
Joshua D. Brown et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review
Jasmine Turna et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2019)
Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature
Nicole Tartaglia et al.
CANNABIS AND CANNABINOID RESEARCH (2019)
Effects of cannabidiol plus naltrexone on motivation and ethanol consumption
Adrian Viudez-Martinez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Position Paper for the Treatment of Nightmare Disorder in Adults: An American Academy of Sleep Medicine Position Paper
Timothy I. Morgenthaler et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2018)
Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle
Gustavo Gonzalez-Cuevas et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
Fernanda F. Peres et al.
FRONTIERS IN PHARMACOLOGY (2018)
No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Ila M. P. Linares et al.
FRONTIERS IN PHARMACOLOGY (2018)
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor et al.
CNS DRUGS (2018)
Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
Kerri A. Schoedel et al.
EPILEPSY & BEHAVIOR (2018)
Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
Kazuhito Tsuboi et al.
INFLAMMATION AND REGENERATION (2018)
Cannabidiol reduces ethanol consumption, motivation and relapse in mice
Adrian Viudez-Martinez et al.
ADDICTION BIOLOGY (2018)
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors
T. Bakas et al.
PHARMACOLOGICAL RESEARCH (2017)
Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference
Jed Black et al.
SLEEP MEDICINE (2017)
Cannabis, Cannabinoids, and Sleep: a Review of the Literature
Kimberly A. Babson et al.
CURRENT PSYCHIATRY REPORTS (2017)
Neurological Aspects of Medical Use of Cannabidiol
Carmen Mannucci et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Cannabidiol, neuroprotection and neuropsychiatric disorders
Alline C. Campos et al.
PHARMACOLOGICAL RESEARCH (2016)
Endocannabinoid Signaling Regulates Sleep Stability
Matthew J. Pava et al.
PLOS ONE (2016)
Roles for the endocannabinoid system in ethanol-motivated behavior
Angela N. Henderson-Redmond et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review
Gustavo A. Angarita et al.
ADDICTION SCIENCE & CLINICAL PRACTICE (2016)
Assessment and treatment of insomnia in adult patients with alcohol use disorders
Kirk J. Brower
ALCOHOL (2015)
The Association of Alcohol Severity and Sleep Quality in Problem Drinkers
Emily E. Hartwell et al.
ALCOHOL AND ALCOHOLISM (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Topiramate in Alcohol Use Disorders: Review and Update
Riccardo Guglielmo et al.
CNS DRUGS (2015)
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
Yasmin L. Hurd et al.
NEUROTHERAPEUTICS (2015)
The clinical pharmacology of acamprosate
Nicola J. Kalk et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
Lili Yang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders
Moshe Laudon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
M. H. N. Chagas et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
The Effects of Quetiapine on Sleep in Recovering Alcohol-Dependent Subjects A Pilot Study
Subhajit Chakravorty et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Endocannabinoid Modulation of Cortical Up-States and NREM Sleep
Matthew J. Pava et al.
PLOS ONE (2014)
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
Celia J. A. Morgan et al.
ADDICTIVE BEHAVIORS (2013)
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report
J. A. S. Crippa et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2013)
An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics
Jeremy R. Johnson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2013)
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats
Marcos Hortes N. Chagas et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography
J. Hirvonen et al.
MOLECULAR PSYCHIATRY (2013)
Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans
Ana B. Fagundo et al.
PLOS ONE (2013)
A review of the interactions between alcohol and the endocannabinoid system: Implications for alcohol dependence and future directions for research
Matthew J. Pava et al.
ALCOHOL (2012)
Sleep Disturbance in Alcoholism: Proposal of a Simple Measurement, and Results from a 24-Week Randomized Controlled Study of Alcohol-Dependent Patients Assessing Acamprosate Efficacy
Pascal Perney et al.
ALCOHOL AND ALCOHOLISM (2012)
A Double-Blind, Placebo-Controlled Trial to Assess the Efficacy of Quetiapine Fumarate XR in Very Heavy-Drinking Alcohol-Dependent Patients
Raye Z. Litten et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)
Prevalence and Correlates of Insomnia in a Polish Sample of Alcohol-Dependent Patients
Nataliya Zhabenko et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)
Positron Emission Tomography Shows Elevated Cannabinoid CB 1 Receptor Binding in Men with Alcohol Dependence
Alexander Neumeister et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)
Dim Light Melatonin Onset in Alcohol-Dependent Men and Women Compared with Healthy Controls
Deirdre A. Conroy et al.
CHRONOBIOLOGY INTERNATIONAL (2012)
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids
Antonio Luchicchi et al.
MOLECULAR NEUROBIOLOGY (2012)
Orexin receptor antagonism for treatment of insomnia A randomized clinical trial of suvorexant
W. Joseph Herring et al.
NEUROLOGY (2012)
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats
Yi-Tse Hsiao et al.
NEUROPHARMACOLOGY (2012)
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
Roger G. Pertwee
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Mirtazapine in Comorbid Major Depression and Alcohol Dependence: An Open-Label Trial
Jack R. Cornelius et al.
JOURNAL OF DUAL DIAGNOSIS (2012)
Gabapentin Combined With Naltrexone for the Treatment of Alcohol Dependence
Raymond F. Anton et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Ramelteon and Improved Insomnia in Alcohol-Dependent Patients: A Case Series
Kirk J. Brower et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2011)
Hooked on benzodiazepines: GABAA receptor subtypes and addiction
Kelly R. Tan et al.
TRENDS IN NEUROSCIENCES (2011)
Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics
David J. Nutt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Prevalence and Correlates of Withdrawal-Related Insomnia among Adults with Alcohol Dependence: Results from a National Survey
Kirk J. Brower et al.
AMERICAN JOURNAL ON ADDICTIONS (2010)
Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin
Barbara J. Mason et al.
ADDICTION BIOLOGY (2009)
The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
George A. Fraser
CNS NEUROSCIENCE & THERAPEUTICS (2009)
Efficacy of a Combination of Flumazenil and Gabapentin in the Treatment of Alcohol Dependence Relationship to Alcohol Withdrawal Symptoms
Raymond F. Anton et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Endocannabinoid System: Emerging Role from Neurodevelopment to Neurodegeneration
Balapal S. Basavarajappa et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Impact of Alcoholism on Sleep Architecture and EEG Power Spectra in Men and Women
Ian M. Colrain et al.
SLEEP (2009)
Trazodone for sleep disturbance after alcohol detoxification: A double-blind, placebo-controlled trial
Peter D. Friedmann et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia
Kirk J. Brower et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment - US multisite randomized controlled trial
Bankole A. Johnson et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Low-dose quetiapine is not a benign sedative-hypnotic agent
James J. Gugger et al.
AMERICAN JOURNAL ON ADDICTIONS (2008)
Gabapentin reduces alcohol consumption and craving: A randomized, double-blind, placebo-controlled trial
Fernando A. Furieri et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Treatment options for sleep disturbances during alcohol recovery
J. Todd Arnedt et al.
JOURNAL OF ADDICTIVE DISEASES (2007)
Cannabidiol - Recent advances
Raphael Mechoulam et al.
CHEMISTRY & BIODIVERSITY (2007)
Quetiapine lowers sympathetic and hyperthermic reactions due to cerebral injection of orexin A
M. Monda et al.
NEUROPEPTIDES (2006)
Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: A multicentre, open label study
Su-Jung Yoon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects
Luc Staner et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2006)
Secondary insomnia in the primary care setting: review of diagnosis, treatment, and management
Larry Culpepper
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine
DA Schmid et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The mechanisms of action of gabapentin and pregaballin
GJ Sills
CURRENT OPINION IN PHARMACOLOGY (2006)
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
M Kathmann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine
JH Shen et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2006)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity
C Hamelink et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Cannabinoid receptors and their relationships with neuropsychiatric disorders
F Gambi et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2005)
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification
J Liappas et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals - A randomized controlled trial
BA Johnson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcoholics
SR Currie et al.
ADDICTION (2004)
Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: Polysomnographic and clinical evaluations
O Le Bon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Use of sleep hygiene in the treatment of insomnia
EJ Stepanski et al.
SLEEP MEDICINE REVIEWS (2003)
Topiramate selectively attenuates nicotine-induced increases in monoamine release
WK Schiffer et al.
SYNAPSE (2001)
Sleep and the cholinergic rapid eye movement sleep induction test in patients with primary alcohol dependence
H Gann et al.
BIOLOGICAL PSYCHIATRY (2001)
Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares
MD Warner et al.
PHARMACOPSYCHIATRY (2001)
Share Paper
